Zekun Li, PhD

Ph.D.
Department II of Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, China
Beijing, Beijing, China (People's Republic)

Zekun Li, PhD, MD, Resident of Hematology Department, Beijing Children's hospital, Capital Medical University, Beijing, China. Research directions are haemophilia and thrombosis. For example, the develop and eradication of inhibitor against FVIII and FIX, and thrombophilia, catheter related thrombosis. Recently focus on maternal microchimerism in hemophilia children, and model of inhibitor decay.

Presentation(s):

• PB0506 - Influence of F8 gene mutation on outcome in immune tolerance induction of hemophilia A children with inhibitors

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0613 - Real-World Use of Emicizumab in Chinese Children with Hemophilia A: Retrospective Data from a Comprehensive Care Center

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 41.2 - F8 mutations involving deletion of the F8B gene increase inhibitor risk for hemophilia A

  Monday, June 24, 2024
  15:00 – 15:15 ICT

• OC 41.3 - Single-cell sequencing of PBMCs from hemophilia A and hemophilia B patients with inhibitors reveals different immune responses to FVIII and FIX after replacement therapy

  Monday, June 24, 2024
  15:15 – 15:30 ICT